Can You Take NMN With Mounjaro?

Is NMN a supplement or a medicine — and why does that distinction matter here?

NMN is classified as a food supplement in the UK. It is not reviewed or authorised by the MHRA as a medicine, which means it does not go through the same safety, efficacy and interaction-testing process that tirzepatide did before it received its UK licence. That is not a condemnation of NMN, but it is a practical consequence: formal interaction data simply does not exist for the pairing of NMN with tirzepatide or with any GLP-1 medicine.

Drug-interaction databases (the tools prescribers and pharmacists use to check whether two compounds clash) list licensed medicines. Supplements sit outside that system. So when someone asks whether you can take NMN and Mounjaro together, the honest answer is that no clinical trial has tested the combination and no regulatory body has evaluated it. That is different from saying it is dangerous. It means the evidence base has a gap.

NMN is a precursor to NAD+ (nicotinamide adenine dinucleotide), a coenzyme involved in cellular energy pathways. Some researchers are interested in whether raising NAD+ levels might support metabolic function, but the human evidence at this stage is preliminary and the NHS does not recommend NMN supplementation for any condition. If you are also curious about taking NAD+ directly alongside Mounjaro, the same gap in formal interaction data applies.

Could Mounjaro's effect on digestion change how NMN is absorbed?

This is a legitimate question and one that does not get asked enough. Mounjaro works in part by slowing gastric emptying, food (and anything you have swallowed) moves through your stomach more slowly than it would otherwise. For most licensed medicines that are taken orally, this is factored into prescribing advice. For oral supplements, there is no equivalent guidance because absorption studies have not been done alongside tirzepatide.

In practical terms, slower gastric transit could theoretically affect the timing and extent to which NMN reaches the small intestine and enters circulation. Whether that produces a meaningful difference in effect is unknown. It might matter; it might not. The tirzepatide SmPC published on the eMC addresses the gastric-emptying effect in general terms but does not evaluate specific supplements.

A common misconception is that supplements are automatically unaffected by GI medicines because they are "natural". Gastric emptying governs all oral ingestion, synthetic or not. The plant origin of a compound does not insulate it from pharmacokinetic interactions.

If you take NMN on Mounjaro treatment, noting any change in how you feel compared to before treatment is a reasonable thing to share with your prescriber at your next review.

What should you tell your prescriber before starting Mounjaro?

The short answer: everything you take, including supplements. That includes NMN, protein powders, herbal preparations and anything else that is not food. Prescribers do not ask out of administrative habit. Some supplements affect blood pressure, blood sugar, liver enzymes or coagulation in ways that are relevant to a weight-management assessment.

At nume, every consultation is personally read by a GPhC-registered Independent Prescriber, not processed by software. Your answers about current supplements are part of what they review. There are no trick questions and no reason to leave anything out, the goal is to understand your full health picture before making a prescribing decision.

If you are already on Mounjaro and have since started NMN, mention it at your next repeat review. You do not need to stop either until you have had that conversation, but the prescriber should know. Our general FAQs cover what to expect from the review process if you are unfamiliar with how it works.

Situations that prompt slightly more careful thought include: taking NMN alongside medicines for blood pressure or blood sugar (given that both of those may already be shifting on Mounjaro), or taking high-dose NMN products that contain other co-ingredients. Some NMN products include additional compounds (resveratrol and pterostilbene are common additions) and those carry their own, equally under-studied, interaction profiles. It is also worth knowing that combining other GLP-1 medicines with Mounjaro raises its own separate set of considerations that your prescriber will want to weigh up.

Is there anything specific to watch for?

Because the combination has not been formally studied, there is no defined list of warning signs unique to NMN-plus-Mounjaro. The more useful framing is: be alert to anything unexpected that starts or worsens after combining the two.

The side effects most commonly associated with Mounjaro are gastrointestinal, nausea, changes in bowel habit, reflux, reduced appetite. These are well-documented and the NHS tirzepatide page sets them out clearly. If GI symptoms feel more pronounced than expected or you notice anything unrelated to the GI tract, flag it with your prescriber rather than assuming it is NMN, Mounjaro or neither. People who already live with gut sensitivities may find it helpful to read about how Mounjaro interacts with IBS, since overlapping gastrointestinal symptoms can make it harder to identify what is driving any change. Similarly, if you are unwell and wondering whether it is safe to continue Mounjaro while you have flu, that is another situation worth discussing with your prescriber promptly.

For context on how similar questions play out with other compound types, the guidance around taking HRT alongside Mounjaro is instructive: even well-studied combinations sometimes carry nuances that a prescriber needs to factor in. Supplements are no different in principle, even if the evidence base is thinner. The right person to make the call is always the clinician with access to your notes, not a general information page.

If you want to discuss your specific supplement list in the context of starting treatment, check your eligibility and start a free consultation with our prescribers.